Login / Signup

Long-term explantation risk in patients with chronic pain treated with spinal cord or dorsal root ganglion stimulation.

Kliment GatzinskyBeatrice BrinkKristin Lilja EyglóardóttirTobias Hallén
Published in: Regional anesthesia and pain medicine (2024)
Although SCS and DRG stimulation are well-established and safe treatments for chronic pain, the long-term explantation risk remains high. The difference between manufacturers highlights the importance of technological evolution for improving therapy outcomes. Increased stringency in patient selection and follow-up strategies, as well as further development of device hardware and software technology for increased longevity, could possibly reduce long-term explantation risks.
Keyphrases
  • chronic pain
  • spinal cord
  • neuropathic pain
  • pain management
  • spinal cord injury
  • type diabetes
  • case report
  • stem cells
  • metabolic syndrome
  • adipose tissue
  • climate change
  • insulin resistance
  • smoking cessation